Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis.

Authors:
Zhao H; Ding Y; Yang J; Luo Y; Xu Z and 1 more

Journal:
Ther Adv Chronic Dis

Publication Year: 2022

DOI:
10.1177/20406223221129163

PMCID:
PMC9549182

PMID:
36225670

Journal Information

Full Title: Ther Adv Chronic Dis

Abbreviation: Ther Adv Chronic Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the National Natural Science Foundation of China (No. 82003720), the Natural Science Foundation of Zhejiang (No. LYY22H310002), and the Foundation of Zhejiang Chinese Medical University (No. Q2019Y02)."

Evidence found in paper:

"This meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement. The protocol was registered in PROSPERO (registration number: CRD42022309845). Because the current research was based on the published data, no consent statement and ethical approval are required."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025